Skip to main content
. 2022 Nov 30;13:1054539. doi: 10.3389/fimmu.2022.1054539

Table 3.

Assessment of bias risk using NOS scale for case-control studies.

Selection Comparability Exposure
References Is the case definition adequate? Representatives of the case Controls selection Controls definition Comparability of cases and controls based on the design or analysis Ascertainment of exposure Same method of ascertainment for cases and controls Non-response rate
Abji, 2017 (34) A* A* B A* A* D A* C
Ahmed, 2014 (109) A* B A* A* AB** D A* C
Alenius, 2002 (93) A* B B A* D A* C
Alenius, 2004 (20) A* B A* B B* D A* C
Alenius, 2009 (102) A* B B A* D A* C
Alonso, 2016 (64) C B B B B* D A* C
Amin, 2016 (59) A* A* C A* A* D A* C
Arias de la rosa, 2020 (125) A* B B A* A* D A* C
Armas-Gonzales, 2015 (58) A* B B A* D A* C
Ausavarungnirun, 2017 (66) A* A* B A* AB** D A* C
Bandinelli, 2015 (86) A* B B D A* C
Batliwalla, 2006 (22) A* B A* B A* D A* C
Bosè, 2014 (55) A* B B B D A* C
Bowes, 2011 (25) A* A* B B* D A* C
Boyd, 2020 (129) A* A* A* B D A* C
Butt, 2007 (24) A* A* A* A* B* D A* C
Calzavara, 1999 (43) A* B C B D A* C
Caputo, 2020 (37) A* A* B A* A* D A* C
Cascella, 2017 (33) A* A* B A* D A* C
Celis, 2011 (104) A* B D C
Chandran, 2010 (10) A* A* B A* AB** D A* C
Chandran, 2014 (30) A* B B A* A D A* C
Chandran, 2019 (15) A* B B A* A* D A* C
CheleschI, 2021 (42) A* A* B A* A* C A* C
Chen, 2019 (35) A* B C A* B* D A* C
Chou, 2010 (44) A* A* B A* A D A* C
Chung, 2021 (92) A* A* C A* A* D A* C
Ciancio, 2017 (32) A* B C A* D A* C
Colak, 2018 (121) A* A* D
Coras, 2019 (120) A* B D
Coras, 2019 (123) A* B D
Coras, 2021 (130) A* A* A* B A* D A* C
Cretu, 2014 (11) A* B B A* AB** D A* C
Cretu, 2018 (24) A* B A* A* B* D A* C
Cuervo, 2021 (73) A* A* B A* B* D A* C
Dalbeth, 2010 (89) A* B B A* D A* C
Dalmády 2013 (45) A* A* A* A* D A* C
Diani, 2019 (16) A* A* C B A* D A* C
Dikbas, 2014 (113) A* B C B D A* C
Dolcino, 2014 (46) A* B C A* B* D A* C
Dolcino, 2015 (12) A* A* C A* AB** D A* C
Eder, 2011 (26) A* A* A* A* D A* C
Eder, 2012 (27) A* B B B D A* C
Eissa, 2013 (107) B B B B AB** D A* C
Ek, 2021 (80) B A* B A* A* D A* C
Elkayam, 2000 (98) A* B B D A* C
Elkayam, 2000 (97) A* B C B D A* C
Elkayam, 2004 (19) A* A* C B D A* C
Esawy, 2020 (71) A* A* B A* D A* C
Farouk, 2010 (9) A* A* A* B AB** D A* C
Farrag, 2017 (68) A* A* C A* AB** D A* C
Fink, 2007 (100) A* B C A* D A* C
Firuzi, 2008 (53) A* B C A* D A* C
Foell, 2003 (87) B B C B D A* C
Frasca, 2018 (48) A* B B A* A* D A* C
Grossi, 2017 (65) A* A* C A* D A* C
Gudmann, 2016 (60) A* A* A* B B* D A* C
Hansson, 2014 (54) A* B C B AB** D A* C
Helliwell, 1991 (84) A* B D
Hu, 2018 (47) A* B C A* A* D A* C
Husakova, 2015 (101) A* B C B A* D A* C
Ibrahim, 2017 (96) A* B C B A* D A* C
Inciarte-Mundo, 2016 (115) A* B B A B* D A* C
Jadon, 2017 (13) A* A* A* A* AB** D A* C
Jarlborg, 2020 (126) B A* B A* A* D A* C
Jensen, 2012v (106) A* B B A* A* D A* C
Kane, 2003 (87) A* B B A* D A* C
Kayikci, 2013 (97) A* A* C B D A* C
Kim, 2015 (57) A* A* B A* AB** D A* C
Kishikawa, 2021 (75) A* A* B B A* C A* C
Korendowych, 2005 (94) A* B D
Leijten E, 2021 (74) A* A* B B A* C A* C
Leijten EF, 2021 (79) A* A* B A* A* C A* C
Lin, 2020 (38) A* B C A* D A* C
Looby, 2021 (78) A* A* B A* A* D A* C
Madland, 2007 (101) A* B D
Maejima, 2014 (56) A* B C A* A* A* C
Maejima, 2017 (67) B A* C B D A* C
Maejima, 2017 (118) A* B B B D A* C
Mansson, 2001 (8) A* A* A* A* D A* C
Marzaioli, 2022 (82) A* A* B A* A* D A* C
Matt, 2015 (111) A* B C B A* D A* C
Mc Ardle, 2021 (83) A* A* B A* A* D A* C
McHugh, 2003 (85) A* B A*
Medvedeva, 2020 (127) A* B B A A* A* C
Munk, 2015 (114) A* B C B A* D A* C
Muntyanu, 2016 (61) A* A* B A* D A* C
Ozisler, 2019 (124) A* B C B A* D A* C
Pasquali, 2020 (39) A* A* B A* A* D A* C
Peled, 2015 (112) A* B B A* B* D A* C
Perez-Alamino, 2014 (95) A* B D
Pongratz, 2010 (103) A* A* D
Przepiera-Będzak, 2013 (105) A* B C B A* D A* C
Przepiera-Będzak, 2016 (116) A* B C B A* D A* C
Ramonda, 2013 (91) A* A* C B A* D A* C
Ravindran, 2004 (21) A* A* A* B D A* C
Reindl, 2016 (63) A* B C B D A* C
Rooney, 2004 (99) A* B C B D A* C
Sakellariou, 2019 (122) A* B B B A* D A* C
Sinkeviciute, 2020 (69) A* B C B D A* C
Skoumal, 2008 (88) A* B B A* D A* C
Smith, 2020 (36) A* B A* A* D A* C
Souto-Carneiro, 2020 (72) B B B B B* D A* C
Stoeckmann, 2006 A* B C A* A* D A* C
Szodoray, 2007 (52) A* B C A* AB** D A* C
van Kuijk, 2010 (90) A* A* D C
Veale, 1993 (51) A* B C A* AB** D A* C
Vinci, 2020 (50) A* B B B D A* C
Wade, 2018 (119) A* B B B D A* C
Wang N., 2022 (81) A* A* B A* A* D A* C
Waszczykowski, 2020 (17) A* A* C A* A* D A* C
Waszczykowski, 2021 (18) A* B C A* A* D A* C
Wcisło-Dziadecka, 2020 (128) B B C A* D A* C
Winchester, 2012 (28) A* A* B A* B* D A* C
Yuan, 2019 (49) A* B B B AB** D A* C
Zhang, 2016 (31) A* B A* A* B* D A* C
Zhu, 2021 (77) A* A* B B A* D A* C

Selection. 1) Is the case definition adequate? A: yes, with independent validation*; B: yes, eg record linkage or based on self-reports; C: no description.

2) Representativeness of the cases A) consecutive or obviously representative series of cases*; B) potential for selection biases or not stated.

3) Selection of Controls A: community controls*; B: hospital controls; C: no description.

4) Definition of Controls A: no history of disease (endpoint)*; B: no description of source.

Comparability. Comparability of cases and controls on the basis of the design or analysis A: study controls for …*; B: study controls for any additional factor*.

Exposure. 1) Ascertainment of exposure A: secure record (eg surgical records)*; B: structured interview where blind to case/control status; C: interview not blinded to case/control status; D: written self-report or medical record only; E: no description.

2) Same method of ascertainment for cases and controls A: yes*; B: no.

3) Non-Response rate A: Same rate for both groups*; B: non respondents described; C: rate different and no designation.